Figure 1: Incidence of anti-retinal autoantibodies in 3 groups of patients: CAR group - patients with symptoms of cancer associated retinopathy, Cancer group - patients with gynecological cancers without visual problems, Control group - healthy subjects. The presence of autoantibodies against human retinal proteins was investigated in the following gynecological cancers: endometrial, cervical, ovarian, and fallopian tube. The graph represents percent of seropositive patients within each group compared to controls.